Matthew Gewirtz, M.D.
NPI 1417909771 · Ophthalmology Physician · Warren, NJ
Enrolled with Medicare as Practitioner - Ophthalmology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Matthew Gewirtz, M.D. is a Ophthalmology Physician provider in Warren, NJ (NPI 1417909771).
Provider details
- NPI number
- 1417909771
- Entity type
- Individual
- Primary specialty
- Ophthalmology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- License
- MA08045900 (NJ)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
4,177 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Complete Exam of Visual System92014 | 841 | $146 |
| Imaging of Retina92134 | 704 | $47 |
| Established Patient Problem Focused Exam of Visual System92012 | 673 | $105 |
| Extended Exam of the Back Part of the Eye With Optic Nerve Drawing92202 | 653 | $17 |
| Injection of Drug Into Eye67028 | 435 | $141 |
| Ultrasound Scan to Determine Eye Length and Lens Power76519 | 234 | $38 |
| Exam of Visual Field With Extended Testing |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 23 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Latanoprost | 366 | 99 |
| Prednisolone Acetate | 320 | 195 |
| Ciprofloxacin Hcl | 263 | 176 |
| Timolol Maleate | 164 | 39 |
| Bimatoprostbrand: Lumigan | 103 | 23 |
| Tobramycin/Dexamethasonebrand: Tobramycin-Dexamethasone | 99 | 71 |
| Brimonidine Tartrate | 98 | 33 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$673 across 11 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-05-16
- Last updated
- 2007-07-08
Frequently asked questions
- What is Matthew Gewirtz's NPI number?
- Matthew Gewirtz's National Provider Identifier (NPI) is 1417909771, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Matthew Gewirtz's specialty?
- Matthew Gewirtz is listed in the NPPES registry with a primary specialty of Ophthalmology Physician (Allopathic & Osteopathic Physicians).
- Where is Matthew Gewirtz located?
- Matthew Gewirtz's practice location on file with NPPES is 65 Mountain Blvd Ext, Warren, NJ 07059-2632.
- What is Matthew Gewirtz's phone number?
- The practice phone number listed in the NPPES registry for Matthew Gewirtz is (732) 356-6200.
- Does Matthew Gewirtz accept Medicare?
- Matthew Gewirtz is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Matthew Gewirtz's NPI active?
- Yes — Matthew Gewirtz's NPI (1417909771) is active in the NPPES registry as of the last update on 2007-07-08.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.